中信建投:人形機器人行業正處於高景氣週期 建議關注靈巧手產業鏈相關標的
中信建投研報稱,人形機器人本體廠商積極發佈產品更新,靈巧手發展值得關注。2025年作為人形機器人量產元年,行業正處於百家爭鳴的高景氣週期,需求將倍數級增長,是驅動板塊表現高升的底層支撐。智元機器人、越疆機器人、優必選科技、開普勒等本體廠商發佈產品更新,中信建投預計後續各個主機廠商的產品更新與發佈仍將為板塊帶來持續催化。此外,雷賽智能發佈靈巧手、均普機器人研究院與禾川機器人官宣戰略合作、五洲新春與新劍傳動簽署戰略合作協議,供應鏈零部件的性能提升和快速降本也是關注的重點,尤其是靈巧手環節,作為重要的任務執行部件,其下游應用廣泛,建議關注產業鏈相關標的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.